Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3738521010 | Product containing only benzocaine and tyrothricin in oromucosal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3738522015 | Benzocaine and tyrothricin only product in oromucosal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only benzocaine and tyrothricin in oromucosal dose form (medicinal product form) | est un(e) (attribut) | Benzocaine and tyrothricin only product | true | Inferred relationship | Some | ||
| Product containing only benzocaine and tyrothricin in oromucosal dose form (medicinal product form) | a pour principe actif (attribut) | Benzocaine (substance) | true | Inferred relationship | Some | 2 | |
| Product containing only benzocaine and tyrothricin in oromucosal dose form (medicinal product form) | est un(e) (attribut) | Benzocaine- and tyrothricin-containing product in oromucosal dose form | true | Inferred relationship | Some | ||
| Product containing only benzocaine and tyrothricin in oromucosal dose form (medicinal product form) | a pour principe actif (attribut) | tyrothricine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing only benzocaine and tyrothricin in oromucosal dose form (medicinal product form) | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
| Product containing only benzocaine and tyrothricin in oromucosal dose form (medicinal product form) | a une forme pharmaceutique (attribut) | forme oromuqueuse | true | Inferred relationship | Some | ||
| Product containing only benzocaine and tyrothricin in oromucosal dose form (medicinal product form) | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | est un(e) (attribut) | True | Product containing only benzocaine and tyrothricin in oromucosal dose form (medicinal product form) | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR